INTERNATIONAL PATENT: SCANDINAVIAN BIOPHARMA HOLDING AB FILES APPLICATION FOR "ORAL VACCINE AGAINST MULTIPLE DIARRHEA-CAUSING PATHOGENS"

GENEVA, March 2 -- SCANDINAVIAN BIOPHARMA HOLDING AB (Industrivagen 1 4tr17148 Solna) filed a patent application (PCT/EP2025/073847) for "ORAL VACCINE AGAINST MULTIPLE DIARRHEA-CAUSING PATHOGENS" on Aug 21, 2025. With publication no. WO/2026/041729, the details related to the patent application was published on Feb 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SJOSTRAND, Bjorn (Per Horbergs Vag 1216850 Bromma), CARLIN, Nils (Kvarnstugvagen 3116839 Bromma)

Abstract: A vaccine comprising effective amounts of i) E. coli colonization factor antigens comprising CFA/I, CS3, CS5 and CS6 anti...